FSD Pharma Rebrands As Quantum BioPharma: Major Share Consolidation Announced
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 12 2024
0mins
Source: Benzinga
Corporate Changes: FSD Pharma Inc. will undergo a share consolidation and rebrand to Quantum BioPharma Ltd., effective August 15, 2024, to enhance its market position and comply with Nasdaq listing requirements.
Private Placement: The company plans a non-brokered private placement of Class A Multiple Voting Shares at $18.00 each, aimed at restoring voting rights for shareholders and positioning itself for future growth in biotech solutions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
